- info@anseaconsulting.com
- Singapore: +65 6956 6164
- Basel: +41 61 564 1420
To validate the business case & develop access strategy & tactics before the launch of the rare disease portfolio in India.
Mapped the patient journey, completed stakeholder mapping, developed bottoms-up patient model, conducted workshop with core client team to validate the assumptions, finalized the financials & market access tactics through cross-functional discussion
Stakeholder map, patient model & financials, access strategy & tactics per stakeholder group
Recommendations adopted by the organization for the investment case for India, including the suggested access strategy & tactics before the launch of the rare disease portfolio in India